Latest Articles

  • DXA and fracture risk assessment
    Cleveland Clinic Journal of Medicine December 2021, 88 (12) 659;

    The following article contained an error: Williams S, Khan L, Licata AA. DXA and clinical challenges of fracture risk assessment in primary care. Cleve Clin J Med 2021; 88(11):615–622. doi:10.3949/ccjm.88a.20199

  • Peyronie disease and erectile dysfunction: A potential new paradigm
    Drogo K. Montague, MD
    Cleveland Clinic Journal of Medicine December 2021, 88 (12) 661-663; DOI: https://doi.org/10.3949/ccjm.88a.21027

    Viewing Peyronie disease as related to erectile dysfunction allows for the possibility of preventing the disease in patients with erectile insufficiency.

  • COVID-19 vaccine-induced cellulitis and myositis
    Sathishkumar Ramalingam, MD, Harkesh Arora, MD, Susan Lewis, MD, Kulothungan Gunasekaran, MD, Maheswari Muruganandam, MD, Sivakumar Nagaraju, MD and Priyesh Padmanabhan, MD
    Cleveland Clinic Journal of Medicine December 2021, 88 (12) 648-650; DOI: https://doi.org/10.3949/ccjm.88a.21038

    The day after receiving the second dose of the mRNA vaccine, redness and pain developed at the injection site, eventually involving the whole left arm and shoulder.

  • Updated guidelines for immune thrombocytopenic purpura: Expanded management options
    Sherwin DeSouza, MD and Dana Angelini, MD
    Cleveland Clinic Journal of Medicine December 2021, 88 (12) 664-668; DOI: https://doi.org/10.3949/ccjm.88a.20201

    The aim is to help practitioners decide on inpatient vs outpatient management, thresholds for initiating treatment, and options for second-line treatment in adults.

  • Chronic venous outflow obstruction: An important cause of chronic venous disease
    Chronic venous outflow obstruction: An important cause of chronic venous disease
    Matthew Harris, MBBS, MRCS and Chung Sim Lim, MBBS, PhD, FRCS, FEBVS
    Cleveland Clinic Journal of Medicine December 2021, 88 (12) 680-688; DOI: https://doi.org/10.3949/ccjm.88a.21068

    A review of the key factors to consider in management of chronic venous outflow obstruction, and advice on how best to get patients the care they need.

  • In Reply: Antiobesity drug therapy
    Yael Mauer, MD, MPH, Marcie Parker, PharmD, BCACP and Sangeeta Kashyap, MD
    Cleveland Clinic Journal of Medicine December 2021, 88 (12) 657-658; DOI: https://doi.org/10.3949/ccjm.88c.12002
  • Metronidazole-induced encephalopathy: Symmetrical hyperintensity on imaging
    Hiroki Matsuura, MD, Takashi Katayama, MD and Kentaro Deguchi, MD, PhD
    Cleveland Clinic Journal of Medicine December 2021, 88 (12) 651-652; DOI: https://doi.org/10.3949/ccjm.88a.21007

    The diagnosis should be based on a combination of the patient’s clinical history, laboratory findings, and imaging results.

  • A perspective on discussing COVID-19 vaccines: Efficacy and adverse effects
    Brian F. Mandell, MD
    Cleveland Clinic Journal of Medicine December 2021, 88 (12) 644-645; DOI: https://doi.org/10.3949/ccjm.88b.12021

    Physicians should be vigilant and open-minded regarding possible adverse reactions to the vaccines, and should take time to discuss the demonstrated efficacy of vaccines with patients.

  • In Reply: Physician resistance to obesity pharmacotherapy
    Yael Mauer, MD, MPH, Marcie Parker, PharmD, BCACP and Sangeeta Kashyap, MD
    Cleveland Clinic Journal of Medicine December 2021, 88 (12) 658-659; DOI: https://doi.org/10.3949/ccjm.88c.12004
  • Changing US trends in contraceptive choices
    Suneela Vegunta, MD, FACP, NCMP, Aakriti R. Carrubba, MD and Megan N. Wasson, DO, FACOG
    Cleveland Clinic Journal of Medicine December 2021, 88 (12) 689-695; DOI: https://doi.org/10.3949/ccjm.88a.20110

    The history and the pros and cons of depot medroxyprogesterone acetate and long-acting reversible contraceptives are examined.

Pages